summary
Introduced
02/24/2025
02/24/2025
In Committee
03/13/2025
03/13/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
Current law requires the Controlled Substances Board to establish a prescription drug monitoring program (PDMP) that requires pharmacies and health care practitioners to generate records documenting the dispensing of monitored prescription drugs. Records from the PDMP may be disclosed to persons specified under current law or by the board by rule. This bill makes changes to certain requirements under the PDMP: 1. Subject to exceptions, current law requires that a patient[s records under the program be reviewed before a practitioner issues a prescription order for the patient. However, current law provides that this requirement does not apply after April 1, 2025. The bill extends the application of this requirement by five years, to April 1, 2030. 2. Current law requires the board to conduct a quarterly review of the PDMP to evaluate the actual outcomes of the PDMP compared with projected outcomes. However, current law provides that this requirement does not apply after October 30, 2025. The bill extends the application of this requirement by five years, to October 30, 2030. For further information see the state fiscal estimate, which will be printed as an appendix to this bill.
AI Summary
This bill extends two key provisions of Wisconsin's Prescription Drug Monitoring Program (PDMP) by five years. First, the bill extends the requirement that healthcare practitioners review a patient's prescription records before issuing a new prescription order until April 1, 2030, instead of the current expiration date of April 1, 2025. Second, the bill extends the Controlled Substances Board's obligation to conduct quarterly reviews of the PDMP's actual outcomes compared to projected outcomes until October 30, 2030, instead of the current expiration date of October 30, 2025. The PDMP is a program designed to track and monitor the dispensing of controlled prescription drugs, helping healthcare providers and authorities prevent potential prescription drug misuse, abuse, and diversion. By extending these provisions, the bill ensures continued oversight and review of prescription drug monitoring practices in Wisconsin for an additional five years.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Laid on the table (on 03/20/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://docs.legis.wisconsin.gov/2025/proposals/reg/asm/bill/ab68 |
| AB68 ROCP for Committee on Health, Aging and Long-Term Care | https://docs.legis.wisconsin.gov/2025/related/records/assembly/health_aging_and_long_term_care/1908798.pdf |
| Fiscal Note - AB68: Fiscal Estimate From DSPS | https://docs.legis.wisconsin.gov/2025/related/fe/ab68/ab68_dsps.pdf |
| BillText | https://docs.legis.wisconsin.gov/document/proposaltext/2025/REG/AB68.pdf |
Loading...